Pangaea Oncology FY net sales up 29 percent year on year

Barcelona 26th April 2016 - Pangaea Oncology closed 2016 with net sales up 29.2 percent at 2.5 million euros ($2.7 million) year on year, FY EBITDA loss widened to 283,000 euros vs loss of 158,000 euros in 2015, FY net loss widened to 595,000 euros vs loss of 487,000 euros in 2015 and FY research and development expenses up 46 percent at 2.7 million euros versus 2015.

Read full press release (Spanish only)


We use first and third party cookies to track your browsing habits on our website in order to provide you with better quality and security, and improve the services offered through this website. If users do not explicitly confirm that they consent to the installation of cookies but continue to browse our website, we will assume that they have agreed and we will inform them accordingly about the possibility of blocking or deleting any previously installed cookies by adjusting their browser settings. You can find out more about cookies in our "Cookie Policy".